Brokers see long-term value despite differing views on near-term upside. The post Where could CSL shares go next? Here's what brokers are predicting appeared first on The Motley Fool Australia.

Confidence has been shaken, but I think the long-term opportunity remains attractive. The post Is CSL a fallen ASX giant to ...

Can CSL shares continue their comeback? The post CSL shares are up 35% since early June. Is the recovery here to stay?

CSL has bounced hard off its lows, and some are already buying back in. But one broker says it's his 'most likely to ...

When Fanatec revealed last year that it was bringing a direct drive wheel base to market for just $350, sim racers sort of lost it. Direct drive is the cream of the crop in terms of force feedback ...

A rebound is here, but can it last? Here's what the experts think. The post After losing half their value, can CSL shares ...

It's been a sad week for CSL Limited (ASX:CSL), who've watched their investment drop 16% to AU$152 in the week since the company reported its interim result. Revenues came in 2.7% below expectations, ...

After an antitrust review knocked 2021’s biggest biopharma buyout off course in May, CSL’s $11.7 billion deal for Swiss iron deficiency specialist Vifor Pharma appears to be back on track. Tuesday, ...

Amid uncertainty for its vaccine division, CSL is growing the footprint of its bread-and-butter plasma therapies business by pledging a capital investment of about $1.5 billion for U.S.-based ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. CSL has started construction ...